NCT07312578 2025-12-31Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell CarcinomaPeking UniversityPhase 2 Enrolling by invitation48 enrolled